243 related articles for article (PubMed ID: 15922070)
1. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
[TBL] [Abstract][Full Text] [Related]
2. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
3. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
4. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
[TBL] [Abstract][Full Text] [Related]
5. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
Kincheski GC; Carobrez AP
Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
[TBL] [Abstract][Full Text] [Related]
6. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
Baptista D; Bussadori K; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Oct; 1294():29-37. PubMed ID: 19635465
[TBL] [Abstract][Full Text] [Related]
7. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
[TBL] [Abstract][Full Text] [Related]
8. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
[TBL] [Abstract][Full Text] [Related]
9. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
10. Further evidence that anxiety and memory are regionally dissociated within the hippocampus.
Bertoglio LJ; Joca SR; Guimarães FS
Behav Brain Res; 2006 Nov; 175(1):183-8. PubMed ID: 16996146
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray.
De Luca-Vinhas MC; Macedo CE; Brandão ML
Pain; 2006 Mar; 121(1-2):94-104. PubMed ID: 16472918
[TBL] [Abstract][Full Text] [Related]
12. Involvement of nitric oxide-dependent pathways of dorsolateral periaqueductal gray in the effects of ethanol in rats submitted to the elevated plus-maze test.
Morato GS; Ortiga RM; Ferreira VM
Behav Brain Res; 2004 Aug; 153(2):341-9. PubMed ID: 15265628
[TBL] [Abstract][Full Text] [Related]
13. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
[TBL] [Abstract][Full Text] [Related]
14. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
Borelli KG; Brandão ML
Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
[TBL] [Abstract][Full Text] [Related]
15. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
Stern CA; Carobrez AP; Bertoglio LJ
Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
[TBL] [Abstract][Full Text] [Related]
16. Reversible inactivation of the dorsal raphe nucleus blocked the antipanic-like effect of chronic imipramine in the elevated T-maze.
Dombrowski PA; Andreatini R
Neurosci Lett; 2006 Oct; 407(1):80-5. PubMed ID: 16959426
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
[TBL] [Abstract][Full Text] [Related]
18. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze.
Albrechet-Souza L; Borelli KG; Brandão ML
J Neurosci Methods; 2008 Mar; 169(1):109-18. PubMed ID: 18190969
[TBL] [Abstract][Full Text] [Related]
19. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
[TBL] [Abstract][Full Text] [Related]
20. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine.
de Araújo Godinho MA; Meneghini L; Lucinda AM; Borges FR; Sakae DY; Marino Neto J; Paschoalini MA; de Lima TC; Faria MS
Behav Brain Res; 2007 Jun; 180(1):86-94. PubMed ID: 17408761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
